Skip to main content
Premium Trial:

Request an Annual Quote

$54M Child and Environment Studies to Include Genomics

NEW YORK (GenomeWeb News) — The National Environmental Health Sciences and the Environmental Protection Agency will grant up to $54 million in total over the next five years to fund centers to study environmental factors in childhood health and well-being, including genomics research and studies of epigenetics and biomarkers for genetic risk.

These Children’s Environmental Health and Disease Prevention Research Centers and Formative Centers programs will have several objectives. They will aim to capitalize on findings from epidemiology studies of pregnant women and children; enhance the use of novel findings in basic research into epigenetics, imaging, and other areas; use biomarkers to characterize the effects of human biology and to predict long-term clinical consequences; train new investigators to study emerging issues in children’s environmental health; and ensure stakeholder participation in the research process.

The agencies will give up to $9 million each year for five years to five grants for the research grants and another $3 million per year for three years to fund a companion program to create CEHC Formative Centers.

The Formative Centers should include new and emerging areas of science in children’s health that incorporate innovative technologies.

Studies at the research centers will include discovery of biomarkers that could predict alterations in development that could be used to test hypotheses about environmental exposures, as well as studies of potential genetic or epigenetic effects that may influence susceptibility to such exposures. Researchers also could use the funding to examine the impact of environmental exposures on aspects of genome stability such as microdeletions or duplications, or those that focus on issues related to communication of genetic and environmental risk-factor information to affected communities.

More information about the Research Centers and Formative Centers programs is available at the NIH website.

The Scan

Panel Recommends Pfizer-BioNTech Vaccine for Kids

CNN reports that the US Food and Drug Administration advisory panel has voted in favor of authorizing the Pfizer-BioNTech SARS-CoV-2 vaccine for children between 5 and 11 years old.

Sharing How to Make It

Merck had granted a royalty-free license for its COVID-19 treatment to the Medicines Patent Pool, according to the New York Times.

Bring it Back In

Bloomberg reports that a genetic analysis has tied a cluster of melioidosis cases in the US to a now-recalled aromatherapy spray.

Nucleic Acids Research Papers on SomaMutDB, VThunter, SCovid Databases

In Nucleic Acids Research this week: database of somatic mutations in normal tissue, viral receptor-related expression signatures, and more.